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ORIGINAL PAPER
Willingness of patients to perform self-management of
asthma and the role of inhaled steroids
Bart P.A. Thoonen1, Tjard R.J. Schermer1, Reinier P. Akkermans1, Joost J. den Otter1 ,
Richard Grol2 and Onno C.P. van Schayck1,3
1Department of General Practice, University Medical Centre St Radboud, Nijmegen, The Netherlands, 2Centre for
Quality of Care Research, University Medical Centre St Radboud, Nijmegen and Maastricht, The Netherlands,
3Department of General Practice, University of Maastricht, The Netherlands.
(43 / 143 5 30%). Subjects with low doses of inhaled steroids (B400Scand J Prim Health Care 2002;20:60–64. ISSN 0281-3432
mcg daily) were most willing to participate (44 / 54 5 81%). Unem-
Objective – Asthma self-management is a generally accepted effec- ployed asthmatics had a higher tendency to participate than patients
with a regular job.tive treatment strategy for asthma patients. Acceptance by patients
may be a barrier for successful implementation. In this study, the role Conclusion – Acceptance of self-management by patients is not a
of inhaled steroids in starting asthma self-management is described. limiting issue in promoting self-management of asthma in general
practice. High acceptance in patients taking low or intermediateDesign – Cross-sectional explorative study.
Setting – General practice. doses of inhaled steroids makes general practice the most appropriate
Subjects – 283 adult steroid-requiring asthma patients were invited setting for self-management. A selection procedure is recommended.
by their GP to participate in a self-management programme.
Key words: asthma, family practice, self-management, cortico-Main outcome measures – In a multivariate logistic regression
steroids.model, the relation between baseline dosage of inhaled steroids,
occupational status, age and sex as independent variables and will-
ingness to participate as dependent variables was explored. Bart P.A. Thoonen, Department of General Practice, University
Medical Centre St Radboud, P.O. Box 9101, 6500 HB Nijmegen,Results – Of all invited, 148 (52%) were willing to participate.
The Netherlands. E-mail: b.thoonen@hsv.kun.nlSubjects not using inhaled steroids were least willing to participate
A key component of asthma guidelines is educating
the patient. The  nding that education should not be
administered without an action plan, self-monitoring
and regular review (1) has led to the introduction of
self-management programmes. Several randomised
controlled trials have demonstrated that self-manage-
ment of asthma is bene cial from the perspective of
both GPs and patients (2,3).
When implementing self-management, there are
certain barriers (time investment, division of tasks,
materials) that may be encountered by GPs, and
setting up an asthma clinic can be a good solution in
overcoming these problems (4). To make this imple-
mentation process more ef cacious, identi cation of
all patients who may pro t from self-management
and selection of those willing to participate in such
treatment strategy are the  rst steps.
One of the key components of asthma self-manage-
ment is tapering off inhaled steroids. Fear and dislike
of inhaled steroids are described as playing a role in
compliance (5,6). It is likely that asthmatics have a
high interest in the possibility of reducing their per-
sonal dosage of inhaled steroids. On the other hand,
subjects using higher doses of inhaled steroids may be
more reluctant as dose reduction may lead to un-
wanted loss of asthma control (7). This paper studies
the role of the dosage of inhaled steroids in the
introduction of self-management in general practice.
Based on  ndings from a pilot study we included age
and sex in this study too (8).
During the initial recruitment we observed that
lack of time due to work was one of the most
frequent reasons for non-participation. Employment
or study thus may be a barrier for patients to partic-
ipate so this factor was included as well.
PATIENTS AND METHODS
In this cross-sectional explorative study, 23 GPs  rst
identi ed all asthma patients requiring inhaled
steroids aged between 16 and 60 years from their
practice population. The information sources used
were problem list codings (based on the International
Classi cation of Primary Care), prescription data
from practice records and the local pharmacist and
annual in uenza vaccination campaign lists. All se-
lected patients were invited to participate in a self-
management programme consisting of three initial
education and training visits, regular (weekly or
daily) self-assessment of symptoms and peak  ow and
adjustment of inhaled steroids according to their
self-assessed asthma condition. Patients could indi-
cate their willingness to participate by returning an
enclosed form to the investigators. Patients who did
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not return the form were classi ed as not willing to
participate. For patients who refused to participate,
or did not respond to the invitation, the following
data were provided anonymously by the subject’s GP:
age, sex, dosage of inhaled steroids and occupational
status. Patients willing to participate were invited to a
lung function laboratory where they were checked for
in- and exclusion criteria, as de ned in Table I, and
data on age, sex, dosage of inhaled steroids and
occupational status were collected.
Analysis
The dependent variable in this study was willingness
to participate (yes:no). Independent variables were
‘usage of inhaled steroids’, ‘occupational status’ age
and sex. Usage of inhaled steroids was de ned as:
none, low dose (B400 mg daily), intermediate dose
(between 400 and 800 mg daily) and high dose (\800
mg daily). Based on presumed differences in effective-
ness and deposition, the dosage of a dry powder
inhaler was halved to obtain equipotent dosages with
metered dose inhalers (9). The cut-off points for
 uticasone were B125, between 125 and 250 and
\250 mg daily for low, intermediate and high doses,
respectively. Occupational status was de ned as being
unemployed versus having a regular (part time) job
or study.
Each of the factors was  rst studied univariate
using the Pearson chi-square test for categorical vari-
ables and Student’s t-test for age. All factors with an
alpha B0.05 were included in a multivariate logistic
Table II. Willingness to participate and the dosage of inhaled
steroids (Pearson chi-square¾61.94, pB0.0001).
Willing to Not willing to
participate (%) participate (%)
100 (70)No inhaled steroids 43 (30)
Low dosage of inhaled 10 (19)44 (81)
steroids
43 (78)Intermediate dosage of 12 (22)
inhaled steroids
High dosage of inhaled 18 (58) 13 (42)
steroids
Total no. of subjects 148 (52) 135 (48)
regression by stepwise forward inclusion of each sep-
arate factor and all  rst-degree interactions between
factors identi ed. The log-likelihood method was
used with a threshold of 0.05 for inclusion of each
factor. Analysis was performed using the SPSS 9
software package (10).
RESULTS
A total of 283 patients were invited by their GPs and
148 (52%) were willing to participate. In Table II, the
relation between use of inhaled steroids and willing-
ness to participate is summarised. The percentage of
non-participants is relatively high in subjects not
using inhaled steroids (although they should) and
there is a reciprocal relationship between dosage of
inhaled steroids and willingness to participate (Pear-
son chi square 61.94, pB0.0001). Based on the selec-
tion criteria de ned, all selected patients should
require inhaled corticosteroids. However, 143 (51%)
of all selected patients were not using inhaled steroids
at the time of selection. Within this group, 43 patients
(43:143 is 30%) were willing to participate. From all
patients who did use inhaled steroids, 105 out of 140
(75%) were willing to participate.
The relation between occupational status and will-
ingness to participate is outlined in Table III. Unem-
ployed subjects have a higher tendency to participate
(Pearson chi square 16.32, pB0.0001).
Table I. Inclusion and exclusion criteria.
Inclusion criteria:
Treated for asthma by the GP
age between 16 and 60 yearsand
and FEV1 more than 40% of the predicted value and
more than 55% of predicted 15 min after inhalation
of 800 mg salbutamol or 6 weeks after inhalation of
800 mg budesonide twice daily
and reversibility FEV1 (after bronchodilation with 800
mg salbutamol MDI or 8 weeks treatment with 800
mg budesonide twice daily) of at least 10% of the
predicted value
or PC20 histamine B¾8 mg:ml
Exclusion criteria:
Smoking history of 15 or more pack years
Serious other diseases than asthma with a low sur-
vival rate
The patient has had exacerbations during a period
of 1 month before the start of the study
Other diseases which in uence bronchial symptoms
and:or lung function (e.g. decompensatio cordis,
sarcoidosis)
The patient is unable to inhale medication correctly
or to measure and record their peak ow adequately
and it is unlikely that this can be taught
Table III. Willingness to participate and occupational status
(Pearson chi-square¾16.320, pB0.0001).
Not willing toWilling to
participate (%)participate (%)
Unemployed 37 (69) 17 (31)
Regular job or study 73 (45)89 (55)
Unknown 22 (33) 45 (67)
Total no. of subjects 148 (52) 135 (48)
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Table IV. Relation between dosage of inhaled steroids, occu-
pational status and willingness to participate: multivariate lo-
gistic model.
Odds ratio 95% con dence
interval
Dosage of inhaled steroids
None 0
10.59 4.70–23.88Low
8.39Intermediate 3.82–18.35
3.06 1.33–7.04High
Occupational status
Unemployed 0
0.40Regular job:education 0.19–0.84
Unknown 0.39 0.17–0.91
The  nding that willingness to participate is lower
in patients with high dosages of inhaled steroids
supports our hypothesis that these patients are truly
steroid dependent. Other studies have shown that
discontinuation of inhaled steroids is often accompa-
nied by exacerbations (7). On the other hand, there is
a substantial group of patients in whom periodic
treatment (14,15) or at least dose reduction (7) has
proved possible.
One of the most striking  ndings in our study was
that 51% of invited patients did not use inhaled
steroids, although they should, on the basis of the
criteria de ned. These criteria were based on national
guidelines for general practice (16,17), which are in
this respect comparable to international guidelines
(3,18). Willingness to participate appears to be associ-
ated with prescription of inhaled steroids. This is an
important  nding, which may be explained by the
selection criteria used in this study. GPs were in-
structed to include all patients possibly requiring
inhaled steroids in their invitation list. Based on
information sources used, GPs could not properly
estimate the need for inhaled steroids in all cases. As
patients who were not willing to participate did not
visit the lung function laboratory we could not verify
their actual need for inhaled steroids. It is justi able
that patients who can do without inhaled steroids are
unwilling to participate. Although it seems obvious
that these subjects will be least willing to participate,
this may be an oversimpli cation. Willingness to
participate may also depend on reasons for not using
inhaled steroids (e.g. steroid resistance, non-compli-
ance) and whether these can be modi ed or not.
Another factor identi ed in this study was the role
of occupational status. The  nding that occupational
status was not always known to the GP hampers
interpretation of our  ndings. If the unknown group
consists of a relatively high number of unemployed
subjects, the difference found might decrease or even
disappear. If there is a relatively high number of
subjects with a regular job or education, the differ-
ence observed could become even more prominent.
Based on our  ndings, the initial observation that
patients with a regular job were more reluctant to
participate in a self-management programme seems
true, but generalisation to all asthma patients is
uncertain.
In our study, we may have underestimated willing-
ness to participate, because of two of our exclusion
criteria: the presence of exacerbations one month
prior to the study and the presence of other diseases
that in uence bronchial symptoms. Earlier studies
indicate that patients are more accessible for a new
treatment strategy closely after having had an exacer-
bation and in the presence of comorbidity (19). Espe-
The mean ages of participants and non-partici-
pants were 38 and 36, respectively (p¾0.078, t-test).
Within the female group, 95 of 181 subjects (53%)
were willing to participate, within the male group this
was 53 out of 102 (52%) (Pearson chi square 0.01,
p-value¾0.932).
Based on the above  ndings, a multivariate logistic
regression model was tested with dosage of inhaled
steroids, occupational status and age. Usage of in-
haled steroids and occupational status were statisti-
cally signi cant independent determinants of
willingness to participate. There were no signi cant
interactions. Table IV gives the results of the tested
model.
DISCUSSION
In this study, dosage of inhaled steroids and occupa-
tional status were identi ed as independent factors
associated with willingness to start asthma self-man-
agement. In general, half of all invited asthmatics are
willing to participate.
In a focus group study exploring views of asthma
patients on self-management, Jones et al. found that
34 out of 35 patients stated that these plans were not
relevant for them personally (11). This is in contrast
to our results and to  ndings by Paterson et al. (12),
who interviewed 120 patients from a nurse run
asthma clinic in general practice. The majority of
patients interviewed were in favour of asthma care
aiming to teach people to manage their asthma for
themselves. Additionally, in a Dutch outpatient clinic
population willingness to participate in a self-man-
agement programme was 68% (13). This comes close
to our  ndings that the participation rate was 75%
within the group of subjects already using inhaled
steroids.
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Table V. Identi cation and assessment of asthma patients possibly interested in self-management.
STEP 3STEP 1 STEP 4STEP 2
Identify asthmatics: Assess need for inhaledAssess current Advised action
steroidssteroids
Not requiredInformation sources: No further actionNo inhaled steroids
problem list codings
Current prescription Required First discuss with patient and
initiate treatmentIn uenza campaign list
Low-intermediate Offer self-management programme
dosage
High dosage Earlier reduction failed No further action
Dosage reduction might be First discuss dose reduction
possible
cially for patients unjustly not using inhaled steroids,
willingness to participate may have been higher had
patients with a recent exacerbation been included.
This study certainly does not cover all possible
factors in uencing the willingness of patients to par-
ticipate in self-management programmes. However,
factors identi ed in this study are all easily accessible
for the GP, making them relevant for a quick assess-
ment. Based on our  ndings, we recommend the
procedure summarised in Table V to select and invite
patients possibly interested in self-management in
general practice.
Finally, results from this study show that most
patients are interested in self-management plans. Ac-
ceptance of guided self-management plans by patients
is therefore not a limiting issue in promoting the use
of self-management of asthma. Patients on low or
intermediate dosages of inhaled steroids were most
willing to participate. As this group is predominantly
treated in general practice, high acceptance of self-
management in this category of patients makes gen-
eral practice the most appropriate setting for this
treatment strategy.
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